Pharmaceutiques – M&A, the race for opportunities
Christophe Pouchoy, Managing Director and Managing Director of Trecento Asset Management, co-manager of the Trecento Santé fund, answered questions from the Pharmaceutiques magazine about the recent acquisitions and some reconciliations of big pharma and major biotech companies. “Because, before buying a company, the laboratories study the expected sales multiples over the coming years and the…